Lewandowski SA - Search Results

1

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.

Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson JA. Williams C, et al. Among authors: lewandowski sa. Oncogene. 2008 Feb 7;27(7):1019-32. doi: 10.1038/sj.onc.1210712. Epub 2007 Aug 13. Oncogene. 2008. PMID: 17700529

2

Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity.

Lewandowski SA, Thiery J, Jalil A, Leclercq G, Szczylik C, Chouaib S. Lewandowski SA, et al. Oncogene. 2005 Jul 14;24(30):4789-98. doi: 10.1038/sj.onc.1208595. Oncogene. 2005. PMID: 15870704

3

The oxysterol receptor LXR inhibits proliferation of human breast cancer cells.

Vedin LL, Lewandowski SA, Parini P, Gustafsson JA, Steffensen KR. Vedin LL, et al. Among authors: lewandowski sa. Carcinogenesis. 2009 Apr;30(4):575-9. doi: 10.1093/carcin/bgp029. Epub 2009 Jan 23. Carcinogenesis. 2009. PMID: 19168586

4

Evaluation of mRNA expression of estrogen receptor beta and its isoforms in human normal and neoplastic endometrium.

Skrzypczak M, Bieche I, Szymczak S, Tozlu S, Lewandowski S, Girault I, Radwanska K, Szczylik C, Jakowicki JA, Lidereau R, Kaczmarek L. Skrzypczak M, et al. Int J Cancer. 2004 Jul 20;110(6):783-7. doi: 10.1002/ijc.20224. Int J Cancer. 2004. PMID: 15170658

5

Estrogen receptor beta. Potential functional significance of a variety of mRNA isoforms.

Lewandowski S, Kalita K, Kaczmarek L. Lewandowski S, et al. FEBS Lett. 2002 Jul 31;524(1-3):1-5. doi: 10.1016/s0014-5793(02)03015-6. FEBS Lett. 2002. PMID: 12135731 Free article. Review.

6

Antitumor activity of tributyrin in murine melanoma model.

Giermasz A, Nowis D, Jalili A, Basak G, Marczak M, Makowski M, Czajka A, Młynarczuk I, Hoser G, Stok osa T, Lewandowski S, Jakóbisiak M. Giermasz A, et al. Cancer Lett. 2001 Mar 26;164(2):143-8. doi: 10.1016/s0304-3835(01)00375-5. Cancer Lett. 2001. PMID: 11179828

7

Imatinib enhances functional outcome after spinal cord injury.

Abrams MB, Nilsson I, Lewandowski SA, Kjell J, Codeluppi S, Olson L, Eriksson U. Abrams MB, et al. Among authors: lewandowski sa. PLoS One. 2012;7(6):e38760. doi: 10.1371/journal.pone.0038760. Epub 2012 Jun 19. PLoS One. 2012. PMID: 22723886 Free PMC article.

8

Response to the report, "A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury" by Sharp et al.

Abrams MB, Nilsson I, Kjell J, Lewandowski S, Codeluppi S, Eriksson U, Olson L. Abrams MB, et al. Exp Neurol. 2014 Jul;257:182-5. doi: 10.1016/j.expneurol.2014.04.025. Epub 2014 May 11. Exp Neurol. 2014. PMID: 24825370 No abstract available.

9

Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.

Lewandowski SA, Fredriksson L, Lawrence DA, Eriksson U. Lewandowski SA, et al. Pharmacol Ther. 2016 Nov;167:108-119. doi: 10.1016/j.pharmthera.2016.07.016. Epub 2016 Aug 12. Pharmacol Ther. 2016. PMID: 27524729 Free PMC article. Review.

10

Pleiotropic activity of systemically delivered angiogenin in the SOD1^G93A mouse model.

Crivello M, O'Riordan SL, Woods I, Cannon S, Halang L, Coughlan KS, Hogg MC, Lewandowski SA, Prehn JHM. Crivello M, et al. Among authors: lewandowski sa. Neuropharmacology. 2018 May 1;133:503-511. doi: 10.1016/j.neuropharm.2018.02.022. Epub 2018 Feb 25. Neuropharmacology. 2018. PMID: 29486168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters